1.
Clinicopathologic Analysis of Malignant Ovarian Germ Cell Tumor;
卵巢恶性生殖细胞肿瘤临床病理分析
2.
Analysis of Prognostic Factors in Patients with Malignant Ovarian Germ Cell Tumor
卵巢恶性生殖细胞肿瘤预后因素分析
3.
Clinical Retrospective Analysis of 34 Malignant Ovarian Germ Cell Tumors;
34例卵巢恶性生殖细胞肿瘤病例的回顾性分析
4.
Clinical Analysis of the 18 Patients with Malignant Ovarian Germ Cell Tumors;
18例卵巢恶性生殖细胞肿瘤的临床分析
5.
Clinical Retropective Analysis of Malignant Ovarian Germ Cell Tumors
卵巢恶性生殖细胞肿瘤病例的临床分析
6.
Clinical Analysis on Fertility-preserving Treatment of Malignant Ovarian Germ Cell Tumors
卵巢恶性生殖细胞肿瘤保留生育功能的临床分析
7.
The Study on uPA, VEGF Expression and Their Significance in Malignant Ovarian Germ Cell Tumor;
uPA、VEGF在卵巢恶性生殖细胞肿瘤中表达及其意义的研究
8.
mixed germ cell tumor of ovary
卵巢混合性生殖细胞肿瘤
9.
Conclusion: 1 .The occurrent rate ofepithelial ovarian tumors (EOT) (57.77%) was significantly higher than that of ovarian germ cell tumors.
结论：（1）卵巢上皮性肿瘤的发生率（57．77％）明显高于生殖细胞肿瘤。
10.
Ovarian cancer: Malignant tumour of the ovaries.
卵巢癌:卵巢的恶性肿瘤。
11.
Grading System for Diagnosis and Treatment of Intracranial Nongerminomatous Malignant Germ Cell Tumors
颅内非生殖细胞瘤性恶性生殖细胞肿瘤的分级诊治
12.
The Correlation of Cellular Proliferation and Apoptosis Related Factors with Ovarian Borderline Tumors;
细胞增殖、凋亡相关因子与卵巢交界性肿瘤相关性的研究
13.
Objective: To study the significance of granulocyte colony stimulating factor( GCSF) expression in malignant ovarian tumor patients.
目的：研究粒细胞集落刺激因子（GCSF）达在恶性卵巢肿瘤患者中的意义。
14.
The Telomerase Activity, Expression and Modulation of hTERT Gene, C-myc Gene in Human Ovarian Tumor Cells;
卵巢恶性肿瘤细胞端粒酶表达和hTERT基因、C-myc基因调控的研究
15.
Considerable Value of Abdominal Dropsy Cytological Examination in the Ovarian Cancer Diagnosis;
腹水细胞学检查对卵巢恶性肿瘤诊断价值的探讨
16.
Expression of Human Leukocyte Antigen-G in Ovarian Cancer
人类白细胞抗原-G在卵巢恶性肿瘤组织中的表达
17.
The detecting analysis of T lymphocyte subsets in peripheral blood of patients with malignant ovarian tumor
恶性卵巢肿瘤患者外周血T淋巴细胞亚群的检测分析
18.
gonocytoma of testis
睾丸生殖母细胞性肿瘤